IPILIMUMAB, MELPHALAN , NIVOLUMAB clinical trials

(CHOPI) Phase 1b/2 Study Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced Uveal Melanoma.

This study is looking at new ways to treat advanced uveal melanoma, a type of eye cancer that has spread. It combines a liver treatment called percutaneous hepatic perfusion with two immunotherapy drugs, ipilimumab and nivolumab, to see if it's safe and helps people live longer without their cancer growing.